期刊文献+

邵铭教授治疗肝硬化的活血化瘀法用药经验

Experience of professor Shao Ming in treating cirrhosis with the Huoxue Huayu therapy
下载PDF
导出
摘要 邵铭教授经过多年临床实践认为血瘀既是肝硬化形成的原因,也是肝硬化病程中始终存在的病理因素,活血化瘀法应贯穿肝硬化治疗的始终。此类患者主要临床表现有右胁肋下隐隐作痛,胀痛或刺痛,入夜尤甚,面色黧黑,身觉乏力。邵铭教授根据经验把化瘀类药物分为四类,分别为血中气药、活血轻药、活血重药、活血猛药。血中气药、轻药主要应用于肝硬化早期;活血重药、猛药适用于器械检查明确有肝硬化结节,肝脏表面凹凸不平的患者。临床应严格辨证论治,区分用药。 Professor Shao Ming, after years of clinical practice, believes that Xueyu (血瘀) is not only the cause of cirrhosis, but also the pathological factors that always exist in the course of cirrhosis. The Huoxue Huayu therapy (活血化瘀法) to dissipate Xueyu should be used throughout the treatment of cirrhosis. The main clinical manifestations of these patients include pain under the right lateral thorax, distending pain or tingling, especially at night, darkish complexion and feeling weak. Professor Shao Ming divided the Huayu medicine (化瘀类) into four groups according to the experience: Xuezhong Qiyao (血中气药), Huoxue Qingyao (活血轻药), Huoxue Zhongyao (活血重药) and Huoxue Mengyao (活血猛药). Xuezhong Qiyao and Qingyao are mainly used in the early stage of liver cirrhosis. Huoxue Zhongyao and Mengyao can be used to patients whose instrument examination showed cirrhosis nodules and uneven liver surface. Clinical treatment should be strictly based on syndrome differentiation, and use medicine differently.
作者 顾姣 邵铭 Gu Jiao
出处 《中医临床研究》 2019年第5期59-61,共3页 Clinical Journal Of Chinese Medicine
关键词 肝硬化 血瘀 活血化瘀 经验 邵铭 Cirrhosis Xueyu Huoxue Huayu Experience Shao Ming
  • 相关文献

参考文献5

二级参考文献29

共引文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部